跳转至内容
Merck
CN
  • An aggregon in conductin/axin2 regulates Wnt/β-catenin signaling and holds potential for cancer therapy.

An aggregon in conductin/axin2 regulates Wnt/β-catenin signaling and holds potential for cancer therapy.

Nature communications (2019-09-20)
Dominic B Bernkopf, Martina Brückner, Michel V Hadjihannas, Jürgen Behrens
摘要

The paralogous scaffold proteins axin and conductin/axin2 are key factors in the negative regulation of the Wnt pathway transcription factor β-catenin, thereby representing interesting targets for signaling regulation. Polymerization of axin proteins is essential for their activity in suppressing Wnt/β-catenin signaling. Notably, conductin shows less polymerization and lower activity than axin. By domain swapping between axin and conductin we here identify an aggregation site in the conductin RGS domain which prevents conductin polymerization. Induction of conductin polymerization by point mutations of this aggregon results in enhanced inhibition of Wnt/β-catenin signaling. Importantly, we identify a short peptide which induces conductin polymerization via masking the aggregon, thereby enhancing β-catenin degradation, inhibiting β-catenin-dependent transcription and repressing growth of colorectal cancer cells. Our study reveals a mechanism for regulating signaling pathways via the polymerization status of scaffold proteins and suggests a strategy for targeted colorectal cancer therapy.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
Triton X-100, laboratory grade
Sigma-Aldrich
单克隆抗 β-肌动蛋白抗体 小鼠抗, clone AC-15, ascites fluid
Millipore
抗-FLAG® 兔抗, affinity isolated antibody, buffered aqueous solution
Roche
抗-GFP, from mouse IgG1κ (clones 7.1 and 13.1)
Sigma-Aldrich
抗-HA 兔抗, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Z-Leu-Leu-Leu-al, ≥90% (HPLC)